Rita Sieracki

Rita Sieracki

Auto-generated profile, based on publicly available information

Rita Sieracki

Medical College of Wisconsin Libraries, Medical College of Wisconsin, Milwaukee

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
BDBinod Dhakal
Binod Dhakal
ASAniko Szabo
Aniko Szabo
SCSaurabh Chhabra
Saurabh Chhabra
MHMehdi Hamadani
Mehdi Hamadani
ADAnita D’souza
Anita D’souza
PHParameswaran N. Hari
Parameswaran N. Hari
High-dose therapy with melphalan followed by autologous stem cell transplant—a combination henceforth referred to as HDT/ASCT—has been the standard treatment for newly diagnosed patients with multiple myeloma (MM) for the past 20 years. Several phase 3 studies conducted before the advent of modern induction therapy with immunomodulatory drugs and proteasome inhibitors (also called “novel agents”)1-4 confirmed that HDT/ASCT was associated with improved response rates (RR), progression-free survival (PFS), and even overall survival (OS) in some studies.2,4 Given the unprecedented efficacy of novel agents, investigators have sought to reevaluate the role of HDT/ASCT. All prospective studies performed in the recent era have consistently shown a PFS benefit,5-8 but their effect on RR and OS compared with the standard-dose therapy (SDT) has been variable.5,6 Some of these discrepancies have been attributed to the use of suboptimal induction regimens, single HDT/ASCT (HDT1) vs tandem HDT/ASCT (HDT2) in the study arm, and inadequate follow-up across studies. The role of HDT2 compared withHDT1 remains unclear, especially after recent results of 2 large randomized trials that had divergent results.9,10 Furthermore, 2 studies7,8 that compared HDT2 with SDT showed OS benefit, but the study that compared HDT1 with SDT did not.5 There are no randomized trials directly comparing HDT1 vs HDT2 and SDT in patients with newly diagnosed MM. Moreover, indirect comparisons of these approaches are not available as well. There is a need to clarify the relative benefits of HDT1 or HDT2 and posttransplant consolidation in the context of modern novel agent induction therapy.

1 November 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
ESElizabeth M. Suelzer
Elizabeth M. Suelzer
JDJennifer Deal
Jennifer Deal
KHKaren L. Hanus
Karen L. Hanus
BRBarbara Ruggeri
Barbara Ruggeri
RSRita Sieracki
Rita Sieracki
EWElizabeth Witkowski
Elizabeth Witkowski
In an era of information overload, it can be challenging to find influential articles in any given field, and one method of identifying such influential articles is to look at citation counts. High citation counts are often equated with articles with high impact factors,1-3 but “impact is not the same as importance or significance.”4(p 290) The raw number does not show the intent of an author in deciding to cite another’s work, and there can be a variety of motivations behind the intent.5,6 For instance, citing a work in a negative manner can be used by researchers to self-correct flawed research and aid in scientific debate.7 Value would be added to citation count numbers if more information was provided concerning the context of the citations.5,6 However, obtaining information about citation characteristics is laborious, and using natural language processing is a relatively new and emerging field.7,8

21 August 2018 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
JFJulia Fritz
Julia Fritz
CWCassandra Walia
Cassandra Walia
AEAbdul Elkadri
Abdul Elkadri
RPRebecca Pipkorn
Rebecca Pipkorn
RDRachel K Dunn
Rachel K Dunn
JCJose Mariano Cabrera
Jose Mariano Cabrera
This systematic review critically analyzes the current research on micronutrient deficiency in children with inflammatory bowel disease (IBD) and synthesizes these data to provide evidence-based guidelines for nutritional surveillance in this population. We searched 5 databases (Ovid Medline, PubMed, Scopus, CINAHL, and Cochrane Library) for studies evaluating micronutrients in patients with IBD using the following inclusion criteria: 1) original research, 2) published 1996 or later; 3) published in English; 4) human subjects; and 5) containing pediatric data. Studies were reviewed and included based on the strength of research methods. Data on the prevalence of micronutrient deficiencies in pediatric patients with IBD and risk factors for micronutrient deficiency in these patients were extracted from included studies and compared and discussed in preparation of the proposed guidelines and manuscript. A total of 39 studies were included in the final review. The data presented in these studies show that iron deficiency and vitamin D deficiency are common in pediatric patients with IBD. Vitamin B12 and folate deficiency are rare. Zinc deficiency, while not common, occurs at a higher rate in patients with Crohn’s disease than in healthy controls. There was limited data on vitamins A, E, and C, and selenium, but deficiency of these micronutrients seems rare. We recommend annual surveillance of iron and vitamin D in pediatric patients with IBD regardless of disease activity or phenotype. Zinc should be monitored annually in patients with Crohn’s disease. There is insufficient evidence to support routine screening for other micronutrient deficiencies.

15 May 2018 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
PDF file
VCVikram J. Christian
Vikram J. Christian
MTMatthew Tallar
Matthew Tallar
CWCassandra L. S. Walia
Cassandra L. S. Walia
RSRita Sieracki
Rita Sieracki
PGPraveen S Goday
Praveen S Goday

1 October 2016 in Medical Decision Making
Verified
Journal Article
Closed access
TCTrafford Crump
Trafford Crump
LBLauren M. Beverung
Lauren M. Beverung
RLRyan Lau
Ryan Lau
RSRita Sieracki
Rita Sieracki
MNMateo Nicholson
Mateo Nicholson
Background. Children’s preferences for health states represent an important perspective when comparing the value of alternative health care interventions related to pediatric medicine, and are fundamental to comparative effectiveness research. However, there is debate over whether these preference data can be collected and used. Purpose. The purpose of this study was to establish psychometric properties of eliciting preferences for health states from children using direct methods. Data Sources. Ovid Medline, PsycINFO, Scopus, EconLit. Study Selection. English studies, published after 1990, were identified using Medical Subject Headings or keywords. Results were reviewed to confirm that the study was based on: 1) a sample of children, and 2) preferences for health states. Data Extraction. Standardized data collection forms were used to record the preference elicitation method used, and any reported evidence regarding the validity, reliability, or feasibility of the method. Data Synthesis. Twenty-six studies were ultimately included in the analysis. The standard gamble and time tradeoff were the most commonly reported direct preference elicitation methods. Seven studies reported validity, four reported reliability, and nine reported feasibility. Of the validity reports, construct validity was assessed most often. Reliability reports typically involved interclass correlation coefficient. For feasibility, four studies reported completion rates. Limitations. The search was limited to four databases and restricted to English studies published after 1990. Only evidence available in published studies were considered; measurement properties may have been tested in pilot or pre-studies but were not published, and are not included in this review. Conclusion. The few studies found through this systematic review demonstrate that there is little empirical evidence on which to judge the use of direct preference elicitation methods with children regarding health states.

1 January 2003 in Journal of Consumer Health on the Internet
Verified
Journal Article
Closed access
MBMary B. Blackwelder
Mary B. Blackwelder
KHKaren Hanus
Karen Hanus
LLLinda Lemahieu
Linda Lemahieu
RSRita Sieracki
Rita Sieracki
AMAhip Mary B. Blackwelder Mls
Ahip Mary B. Blackwelder Mls
Recent surveys indicate that the number of people looking for health information online has skyrocketed. Consumers have access to an abundance of information via the Web, not all of it quality, authoritative information. Bad information can be worse than no information. The Medical College of Wisconsin Libraries partnered with a local public library to offer classes to the public on finding quality health information on the Web. Within three months after each class, a follow-up survey was sent to participants to determine if they had accessed health information online since taking the class, if taking the class had helped them to find information, and if they had used any of the information in making a health care decision or in interacting with their health care provider. Results show that awareness of quality health related Web sites helped consumers to find information that they in turn used in managing their health care decisions.